5
Participants
Start Date
May 31, 2012
Primary Completion Date
July 31, 2012
Study Completion Date
July 31, 2012
IV morphine sulfate
Patients in this group will receive IV morphine sulfate via patient-controlled analgesia (PCA) pump, as needed. The PCA pump will be set up postsurgically as soon as possible and prior to the patient leaving the post-anesthesia care unit (PACU) or immediately upon transfer to the floor if the stay in the PACU is less than 1 hour.
EXPAREL (bupivacaine liposome injectable suspension)
"Patients in this group will receive 266 mg EXPAREL diluted with preservative free 0.9% normal saline to a total volume of 30 cc and administered via wound infiltration prior to wound closure. When not contraindicated, 30 mg IV ketorolac, a non-steroidal anti-inflammatory drug (NSAID), may be substituted per the site's standard of care.~All patients will be offered rescue analgesia, as needed."
University of Miami, Dept of Anesthesiology, Miami
Lead Sponsor
Registrat-Mapi
OTHER
Pacira Pharmaceuticals, Inc
INDUSTRY